The Valley Desk

NCT06596252 · Interventional trial

Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE

Overall registry status Active not recruiting

Phase 3

Conditions Eosinophilic Esophagitis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov